Earnings callsIOL Chemicals & Pharmaceuticals Ltd
Every summarised call, newest first. Latest is Q1 FY27, held 13 Aug 2026.
- Q1 FY27Positive tone
Strong Q1 growth driven by successful diversification beyond ibuprofen, with non-ibu APIs contributing 43% of pharma revenue and a 60.7% EBITDA increase.